(RTTNews) - Traws Pharma, Inc. (TRAW) announced the filing of a U.S. IND application with the FDA for tivoxavir marboxil, a potential CAP-dependent endonuclease inhibitor as a single oral tablet ...
HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the ...
FibroBiologics (FBLG) announced the filing of a Phase 1/2 Investigational New Drug application with the U.S. Food and Drug Administration seeking regulatory clearance to initiate clinical trials of ...
Abpro Holdings Inc. and Celltrion Inc. have announced the submission of an IND application to the FDA for ABP-102 (CT-P72), a HER2 x CD3 T-cell engager. Pending clearance, a phase I trial in patients ...
SHANGHAI and SANTA BARBARA, Calif., Sept. 15, 2025 /PRNewswire/ --Rona Therapeutics, a global leader in developing next-generation RNAi therapeutics, announced today the successful submission of ...
Cassava Sciences (NASDAQ:SAVA) slid 13% in early Monday trading after the company disclosed that the U.S. Food and Drug Administration has asked for more information related to its investigational new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results